NEW YORK (GenomeWeb News) – Shares in Molecular Devices were down more than 17 percent, or $3.75, at $18.09 in mid-afternoon trading after the company today slashed its revenue outlook for the third quarter by between 8 percent and 12 percent.
In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.